A detailed history of Northern Trust Corp transactions in Gh Research PLC stock. As of the latest transaction made, Northern Trust Corp holds 32,193 shares of GHRS stock, worth $292,634. This represents 0.0% of its overall portfolio holdings.

Number of Shares
32,193
Holding current value
$292,634
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$6.69 - $12.49 $215,371 - $402,090
32,193 New
32,193 $215,000
Q4 2023

Feb 13, 2024

BUY
$5.26 - $11.04 $53,325 - $111,923
10,138 New
10,138 $58,000

Others Institutions Holding GHRS

About GH Research PLC


  • Ticker GHRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,020,800
  • Market Cap $473M
  • Description
  • GH Research PLC, a clinical-stage biopharmaceutical company, engages in developing various therapies for the treatment of psychiatric and neurological disorders. The company focuses on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD). Its lead program is GH0...
More about GHRS
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.